Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Novel antithrombotic agent developed at Otsuka

Dec. 11, 1997

No Comments

3-Dimensional Pharmaceuticals discloses new serine protease inhibitors

Dec. 11, 1997

No Comments

Potent, orally active gpIIb/IIIa receptor antagonist for once-daily administration

Dec. 2, 1997

No Comments

Toyama's antiplatelet agent progresses to clinical studies

Nov. 28, 1997

No Comments

Antiplatelet and antithrombotic effects of NSL-9403

Nov. 28, 1997

No Comments

FACT study results reported

Nov. 27, 1997

No Comments

Expanded use approved for ReoPro in Europe

Nov. 26, 1997

No Comments

NDA filed in U.S. for Otsuka antiplatelet agent

Nov. 26, 1997

No Comments

Agrylin approved in Canada

Nov. 25, 1997

No Comments

Lilly claims antithrombotic diamides

Nov. 24, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

BioWorld Science, Hematologic
RSS

Novel antithrombotic agent developed at Otsuka

3-Dimensional Pharmaceuticals discloses new serine protease inhibitors

Potent, orally active gpIIb/IIIa receptor antagonist for once-daily administration

Toyama's antiplatelet agent progresses to clinical studies

Antiplatelet and antithrombotic effects of NSL-9403

FACT study results reported

Expanded use approved for ReoPro in Europe

NDA filed in U.S. for Otsuka antiplatelet agent

Agrylin approved in Canada

Lilly claims antithrombotic diamides

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

BioWorld Science, Hematologic RSS

BioWorld Science, Hematologic
RSS